Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Laser Therapy for Treatment of Urogenital Symptoms in Women

NCT: NCT03681678 · COMPLETED

NCT IDNCT03681678
StatusCOMPLETED
Start Date2018-10-08
Completion2025-06-10
SponsorCorewell Health East (OTHER)
First posted
Last updated

Brief Summary

This is a prospective observational study of women undergoing vaginal treatment with the fractional carbon dioxide (fCO2) laser for various urogenital symptoms.

Frequently Asked Questions

What is Laser Therapy for Treatment of Urogenital Symptoms in Women?

Laser Therapy for Treatment of Urogenital Symptoms in Women is a clinical trial registered under NCT03681678. Current status: COMPLETED.

What is the status of NCT03681678?

The current status of NCT03681678 (Laser Therapy for Treatment of Urogenital Symptoms in Women) is: COMPLETED.

When did Laser Therapy for Treatment of Urogenital Symptoms in Women start?

Laser Therapy for Treatment of Urogenital Symptoms in Women started on 2018-10-08.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.